Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 1
2005 2
2006 6
2007 5
2008 5
2009 1
2010 2
2011 4
2012 3
2013 4
2014 9
2015 2
2016 4
2017 2
2018 3
2019 1
2020 6
2021 3
2022 5
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Immune checkpoint inhibitors for the treatment of melanoma.
Sabbatino F, Liguori L, Pepe S, Ferrone S. Sabbatino F, et al. Among authors: pepe s. Expert Opin Biol Ther. 2022 May;22(5):563-576. doi: 10.1080/14712598.2022.2038132. Epub 2022 Feb 13. Expert Opin Biol Ther. 2022. PMID: 35130816 Free PMC article. Review.
Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives.
Marra A, Ferrone CR, Fusciello C, Scognamiglio G, Ferrone S, Pepe S, Perri F, Sabbatino F. Marra A, et al. Among authors: pepe s. Anticancer Agents Med Chem. 2018;18(2):166-181. doi: 10.2174/1871520618666171219115335. Anticancer Agents Med Chem. 2018. PMID: 29256359 Review.
Immune Checkpoint Inhibitors in Melanoma and HIV Infection.
Marra A, Scognamiglio G, Peluso I, Botti G, Fusciello C, Filippelli A, Ascierto PA, Pepe S, Sabbatino F. Marra A, et al. Among authors: pepe s. Open AIDS J. 2017 Nov 14;11:91-100. doi: 10.2174/1874613601711010091. eCollection 2017. Open AIDS J. 2017. PMID: 29290886 Free PMC article. Review.
PD-L1 Dysregulation in COVID-19 Patients.
Sabbatino F, Conti V, Franci G, Sellitto C, Manzo V, Pagliano P, De Bellis E, Masullo A, Salzano FA, Caputo A, Peluso I, Zeppa P, Scognamiglio G, Greco G, Zannella C, Ciccarelli M, Cicala C, Vecchione C, Filippelli A, Pepe S. Sabbatino F, et al. Among authors: pepe s. Front Immunol. 2021 Jun 7;12:695242. doi: 10.3389/fimmu.2021.695242. eCollection 2021. Front Immunol. 2021. PMID: 34163490 Free PMC article.
Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors.
Liguori L, Polcaro G, Nigro A, Conti V, Sellitto C, Perri F, Ottaiano A, Cascella M, Zeppa P, Caputo A, Pepe S, Sabbatino F. Liguori L, et al. Among authors: pepe s. Pharmaceutics. 2022 Nov 11;14(11):2442. doi: 10.3390/pharmaceutics14112442. Pharmaceutics. 2022. PMID: 36432631 Free PMC article. Review.
[Adjuvant treatment of diabetic foot].
Lo Pardo D, Pezzuti G, Selleri C, Pepe S, Esposito S. Lo Pardo D, et al. Among authors: pepe s. Infez Med. 2012;20 Suppl 1:35-41. Infez Med. 2012. PMID: 22982696 Free article. Review. Italian.
Ipilimumab in the treatment of metastatic melanoma: management of adverse events.
Della Vittoria Scarpati G, Fusciello C, Perri F, Sabbatino F, Ferrone S, Carlomagno C, Pepe S. Della Vittoria Scarpati G, et al. Among authors: pepe s. Onco Targets Ther. 2014 Feb 19;7:203-9. doi: 10.2147/OTT.S57335. eCollection 2014. Onco Targets Ther. 2014. PMID: 24570590 Free PMC article. Review.
74 results